Literature DB >> 17346300

Phadiatop compared to skin-prick test as a tool for diagnosing atopy in epidemiological studies in schoolchildren.

Luis Garcia-Marcos1, Manuel Sanchez-Solis, Antonia E Martinez-Torres, Jose M Lucas Moreno, Vicente Hernando Sastre.   

Abstract

The validity of the Phadiatop test as compared to the skin-prick test (SPT) for diagnosing atopy in the epidemiological field has not been studied in schoolchildren. The aim of the present study was to evaluate its validity for classifying schoolchildren 9-12 yr old into atopics and non-atopics. A total of 621 children whose parents authorized both a SPT and a blood extraction from all children participating in the phase II of the International Study of Allergies in Children (ISAAC) in Cartagena (Spain) were included in the analysis. A positive SPT was that with at least a wheal having a maximum diameter of 3 mm, once the negative value had been subtracted. Phadiatop was performed according to the manufacturer instructions. Diagnostic tests using SPT as the gold standard were calculated for the whole group of children and also for those with asthma or rhinoconjunctivitis and for children without any of them. The results of the tests were: sensitivity 85.0% (95% CI 82.2-87.8%), specificity 85.5% (95%CI 82.7-88.3%), positive predictive value 72.7% (95%CI 69.0-76.1%), negative predictive value 92.7% (95%CI 90.6-94.7%) and accuracy 85.3% (95%CI 82.3-88.0%). The results improved among the symptomatic groups. Phadiatop can be used as a valid alternative to SPT in the epidemiological setting to diagnose atopy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17346300     DOI: 10.1111/j.1399-3038.2006.00508.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  6 in total

Review 1.  Asthma outcomes: biomarkers.

Authors:  Stanley J Szefler; Sally Wenzel; Robert Brown; Serpil C Erzurum; John V Fahy; Robert G Hamilton; John F Hunt; Hirohito Kita; Andrew H Liu; Reynold A Panettieri; Robert P Schleimer; Michael Minnicozzi
Journal:  J Allergy Clin Immunol       Date:  2012-03       Impact factor: 10.793

2.  Pollen-specific immunoglobulin E positivity is associated with worsening of depression scores in bipolar disorder patients during high pollen season.

Authors:  Partam Manalai; Robert G Hamilton; Patricia Langenberg; Susan E Kosisky; Manana Lapidus; Aamar Sleemi; Debra Scrandis; Johanna A Cabassa; Christine A Rogers; William T Regenold; Faith Dickerson; Bernard J Vittone; Alvaro Guzman; Theodora Balis; Leonardo H Tonelli; Teodor T Postolache
Journal:  Bipolar Disord       Date:  2012-02       Impact factor: 6.744

3.  The practical benefit of Phadiatop test as the first-line in vitro allergen-specific immunoglobulin E (sIgE) screening of aeroallergens among Chinese asthmatics: a validation study.

Authors:  Guangqiao Zeng; Haisheng Hu; Peiyan Zheng; Ge Wu; Nili Wei; Xueqing Liang; Baoqing Sun; Xiaowen Zhang
Journal:  Ann Transl Med       Date:  2018-04

4.  Influence of maternal asthma on the cause and severity of infant acute respiratory tract infections.

Authors:  Kecia N Carroll; Tebeb Gebretsadik; Patricia Minton; Kimberly Woodward; Zhouwen Liu; E Kathryn Miller; John V Williams; William D Dupont; Tina V Hartert
Journal:  J Allergy Clin Immunol       Date:  2012-02-14       Impact factor: 10.793

5.  Clinical availability of component-resolved diagnosis using microarray technology in atopic dermatitis.

Authors:  Joon-Seok Choi; Joo-Young Roh; Jong-Rok Lee
Journal:  Ann Dermatol       Date:  2014-07-31       Impact factor: 1.444

6.  Biomarkers of Type 2 Airway Inflammation as Predictors of Loss of Asthma Control During Step-Down Therapy for Well-Controlled Disease: The Long-Acting Beta-Agonist Step-Down Study (LASST).

Authors:  Sonali Bose; Christian Bime; Robert J Henderson; Kathryn V Blake; Mario Castro; Emily DiMango; Nicola A Hanania; Janet T Holbrook; Charles G Irvin; Monica Kraft; Stephen P Peters; Joan Reibman; Elizabeth A Sugar; Kaharu Sumino; Robert A Wise; Linda Rogers
Journal:  J Allergy Clin Immunol Pract       Date:  2020-07-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.